Abstract
Many compounds have been shown to produce liver enlargement and hepatic peroxisome proliferation in rodents (Cohen and Grasso 1981; Reddy and Lalwani 1983). Organelle proliferation is accompanied by large increases in certain enzyme activities, particularly in the peroxisomal fatty acid β-oxidation cycle, which is normally measured as cyanide-insensitive palmitoyl-CoA oxidation (Lazarow and DeDuve 1976). Certain peroxisome proliferators have been shown to increase the incidence of liver tumours in rats and/or in mice and it has been suggested that tumour formation is, in some manner, related to organelle proliferation (Reddy and Lalwani 1983; Reddy et al. 1986).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albro PW, Corbett JT, Schroeder JL, Jordan S, Matthews HB (1982) Pharmacokinetics, interactions with macromolecules and species differences in metabolism of DEHP. Environ Health Perspect 45:19–25.
Barber ED, Astill BD, Moran EJ, Schneider BF, Gray TJB, Lake BG, Evans JG (1987) Peroxisome induction studies on seven phthalate esters. Toxicol Ind Health 3:7–24.
Bingham RC, Dewar MJS, Lo DH (1975) Ground states of molecules. XXV.MINDO/3. An improved version of the MINDO semiempirical SCF-MO method. J Am Chem Soc 97:1285–1293.
Bronfman M, Amigo L, Morales MN (1986) Activation of hypolipidaemic drugs to acyl-coenzyme A thioesters. Biochem J 239:781–784.
Cohen AJ, Grasso P (1981) Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man. Food Cosmet Toxicol 19:585–605.
Elcombe CR, Mitchell AM (1986) Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms. Environ Health Perspect 70:211–219.
Gray TJB, Beamand JA, Lake BG, Foster JR, Gangolli SD (1982) Peroxisome proliferation in cultured rat hepatocytes produced by Clofibrate and phthalate ester metabolites. Toxicol Lett 10:273–279.
Gray TJB, Lake BG, Beamand JA, Foster JR, Gangolli SD (1983a) Peroxisome proliferation in primary cultures of rat hepatocytes. Toxicol Appl Pharmacol 67:15–25.
Gray TJB, Lake BG, Beamand JA, Foster JR, Gangolli SD (1983b) Peroxisomal effects of phthalate esters in primary cultures of rat hepatocytes. Toxicology 28:167–179.
Lake BG, Gangolli SD, Grasso P, Lloyd AG (1975) Studies on the hepatic effects of orally administered di-(2-ethylhexyl) phthalate in the rat. Toxicol Appl Pharmacol 32:355–367.
Lake BG, Gray TJB, Lewis DFV, Beamand JA, Hodder KD, Purchase R, Gangolli SD (1987) Structure-activity relationships for induction of peroxisomal enzyme activities by phthalate monoesters in primary rat hepatocyte cultures. Toxicol Ind Health 3:165–183.
Lake BG, Pels Rijcken WR, Gray TJB, Foster JR, Gangolli SD (1984) Comparative studies of the hepatic effects of di- and mono-n-octyl phthalates, di-(2-ethylhexyl) phthalate and Clofibrate in the rat. Acta Pharmacol Toxicol 54:167–176.
Lazarow PB, DeDuve C (1976) A fatty acyl-CoA oxidizing system in rat peroxisomes; enhancement by Clofibrate, a hypolipidemic drug. Proc Natl Acad Sci USA 73:2043–2046.
Lewis DFV, Lake BG, Gray TJB, Gangolli SD (1987) Structure activity requirements for induction of peroxisomal enzyme activities in primary rat hepatocyte cultures. Arch Toxicol Suppl 11:39–41.
Lück H (1963) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York, pp 885–888.
Mann AH, Price SC, Mitchell FE, Grasso P, Hinton RH, Bridges JW (1985) Comparison of the short-term effects of di(2-ethylhexyl) phthalate, di(n-hexyl) phthalate, and di(n-octyl) phthalate in rats. Toxicol Appl Pharmacol 77:116–132.
Mitchell AM, Lhuguenot JC, Bridges JW, Elcombe CR (1985) Identification of the proximate peroxisome proliferator(s) derived from di(2-ethylhexyl) phthalate. Toxicol Appl Pharmacol 80:23–32.
Mitchell FE, Bridges JW, Hinton RH (1986) Effects of mono(2-ethylhexyl) phthalate and its straight chain analogues mono-n-hexylphthalate and mono-n-octyl phthalate on lipid metabolism in isolated hepatocytes. Biochem Pharmacol 35:2941–2947.
Moody DE, Reddy JK (1978) Hepatic peroxisome (microbody) proliferation in rats fed plas-ticizers and related compounds. Toxicol Appl Pharmacol 45:497–504.
Reddy JK, Lalwani ND (1983) Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and plasticizers to humans. Crit Rev Toxicol 12:1–58.
Reddy JK, Reddy MK, Usman MI, Lalwani ND, Rao MS (1986) Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug. Environ Health Perspect 65:317–327.
Rhodes C, Soames T, Stonard MD, Simpson MG, Vernall AJ, Elcombe CR (1984) The absence of testicular atrophy and in vivo and in vitro effects on hepatocyte morphology and peroxisomal enzyme activities in male rats following the administration of several alkanols. Toxicol Lett 21:103–109.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag
About this paper
Cite this paper
Lake, B.G., Lewis, D.F.V., Gray, T.J.B. (1988). Structure-Activity Relationships for Hepatic Peroxisome Proliferation. In: Chambers, P.L., Chambers, C.M., Dirheimer, G. (eds) The Target Organ and the Toxic Process. Archives of Toxicology, vol 12. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73113-6_36
Download citation
DOI: https://doi.org/10.1007/978-3-642-73113-6_36
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-18512-3
Online ISBN: 978-3-642-73113-6
eBook Packages: Springer Book Archive